CHARIS LLOYD: Open Payments
NPI 1528313525 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 17 payments from 10 companies in 2025. Trend: 2023 $330 · 2024 $246 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 1 | $100 |
| Travere Therapeutics, Inc. | 4 | $71 |
| Novo Nordisk Inc | 2 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Vifor Pharma, Inc. | 2 | $31 |
| Amgen Inc. | 1 | $25 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| Lilly USA, LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: TERLIVAZ, Ozempic, Fabhalta, Veltassa, KRYSTEXXA, FUROSCIX, JARDIANCE, LOKELMA.
Industry payments across SC — which companies pay providers there.
